Sponsor
Nanexa AB
Virdings Alle 2, Vaksala, 754 50 Uppsala, Sweden
About the sponsor
Nanexa AB’s clinical research is centered on type 2 diabetes, with attention to metabolic disease and the development of therapies intended for people living with impaired glucose regulation.
- Glycaemic control
- Metabolic disorder
- Diabetes pharmacology
The sponsor’s activity in this area reflects an interest in advancing therapeutic options for diabetes mellitus through focused clinical investigation.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.